Five years after appearing on the public stage, we will shine a light on the current situation around CRISPR/Cas technology. We will discuss the patents, the spin-offs and the future prospects of the technology.
Five years after appearing on the public stage, we will shine a light on the current situation around CRISPR/Cas technology. We will discuss the patents, the spin-offs and the future prospects of the technology.